山东大学学报 (医学版) ›› 2024, Vol. 62 ›› Issue (3): 107-111.doi: 10.6040/j.issn.1671-7554.0.2024.0124
许沛晨1,李晓博1,2,庄向华1,2,娄能俊1,2,吕丽1,2,周玲雁1,2,牟亚朋1,宋玉文1,2*,陈诗鸿1,2*
中图分类号:
| [1] Alstrom CH, Hallgren B, Nilsson LB, et al. Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness: a specific syndrome(not hitherto described)distinct from the Laurence-Moon-Bardet-Biedl syndrome: a clinical, endocrinological and genetic examination based on a large pedigree[J]. Acta Psychiatr Neurol Scand Suppl, 1959, 129:1-35. [2] Zhang Q, Ding Y, Feng B, et al. Molecular and phenotypic expansion of Alström Syndrome in Chinese patients[J]. front genet, 2022, 13:808919. doi: 10.3389/fgene.2022.808919. [3] 王云芳,万小艳,牛瑞兰,等.Alstrom综合征两例报道[J].中国糖尿病杂志, 2023, 31(2): 139-144. WANG Yunfang, WAN Xiaoyan, NIU Ruilan, et al. Chinese Journal of Diabetes Mellitus, 2023, 31(2): 139-144. [4] Hearn T, Renforth GL, Spalluto C, et al. Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alström syndrome[J]. Nat Genet, 2002, 31(1): 79-83. [5] 付宇,王金堂.Alstrom综合征的发病机制及诊治研究进展[J].山东医药, 2019, 59(18): 87-91. [6] Jagger D, Collin G, Kelly J, et al. Alström Syndrome protein ALMS1 localizes to basal bodies of cochlear hair cells and regulates cilium-dependent planar cell polarity[J]. Hum Mol Genet, 2011, 20(3): 466-481. [7] Hearn T. ALMS1 and Alström syndrome: a recessive form of metabolic, neurosensory and cardiac deficits[J]. J Mol Med(Berl), 2019, 97(1): 1-17. [8] Favaretto F, Milan G, Collin GB, et al. GLUT4 defects in adipose tissue are early signs of metabolic alterations in Alms1GT/GT, a mouse model for obesity and insulin resistance[J]. PLoS One, 2014, 9(10): e109540. doi: 10.1371/journal.pone.0109540. [9] Monu SR, Potter DL, Liao TD, et al. Role of Alström syndrome 1 in the regulation of glomerular hemodynamics[J]. Am J Physiol Renal Physiol, 2023, 325(4): F418-f425. [10] Baig S, Paisey R, Dawson C, et al. Defining renal phenotype in Alström syndrome[J]. Nephrol Dial Transplant, 2020, 35(6): 994-1001. [11] Ademolu AB, Geberhiwot T. Hematopoietic stem cell progenitors driving metabolic disturbance in Alström Syndrome[J]. Endocrinology, 2023, 164(9): bqad110. [12] Quoraishi S, Mason G, Geberhiwot T, et al. Hearing loss in adults with Alström Syndrome-experience from the UK National Alström Service[J]. Otol Neurotol, 2022, 43(6): e620-e627. [13] Tahani N, Maffei P, Dollfus H, et al. Consensus clinical management guidelines for Alström syndrome[J]. Orphanet J Rare Dis, 2020, 15(1): 253. [14] Wang Y, Huang L, Sun L, et al. Ocular findings and genetic test in Alström syndrome in childhood[J]. Exp Eye Res, 2022, 225: 109277. [15] 张倩文, 丁宇, 常国营, 等. 2020年欧洲Alström综合征临床管理指南介绍及解读[J]. 中华实用儿科临床杂志, 2021, 36(13): 961-965. ZHANG Qianwen,DING Yu,CHANG Guoying,et al. Introduction and interpretation of European clinical management guidelines for Alström syndrome in 2020[J]. Chinese Journal of Applied Clinical Pediatrics, 2021, 36(13): 961-965. [16] Nerakh G, Ranganath P. Alström Syndrome presenting as isolated dilated cardiomyopathy[J]. Indian J Pediatr, 2019, 86(3): 296-298. [17] Dedeoglu S, Dede E, Oztunc F, et al. Mutation identification and prediction for severe cardiomyopathy in Alström syndrome, and review of the literature for cardiomyopathy[J]. Orphanet J Rare Dis, 2022, 17(1): 359. [18] Herranz-Heras JC, Barceló A, Quesada-Espinosa JF, et al. Alström syndrome: two clinical cases with two novel pathogenic variants[J]. Eur J Ophthalmol, 2023, 33(4): Np27-np31. [19] Marshall JD, Muller J, Collin GB, et al. Alström Syndrome: mutation spectrum of ALMS1[J]. Hum Mutat, 2015, 36(7): 660-668. [20] Zhou C, Xiao Y, Xie H, et al. A novel variant in ALMS1 in a patient with Alström syndrome and prenatal diagnosis for the fetus in the family: a case report and literature review[J]. Mol Med Rep, 2020, 22(4): 3271-3276. [21] Abosabie SAS, Abosabie SA, Alfaifi J, et al. Unraveling Alström syndrome: homozygous mutation c.2729C>G in ALMS1 gene across an extended family[J]. Mol Genet Genomic Med, 2024, 12(1): e2314. [22] Bea-Mascato B, Valverde D. Genotype-phenotype associations in Alström syndrome: a systematic review and meta-analysis[J]. J Med Genet, 2023, 61(1): 18-26. [23] Engle SE, Bansal R, Antonellis PJ, et al. Cilia signaling and obesity[J]. Semin Cell Dev Biol, 2021, 110: 43-50. [24] Littleton SH, Berkowitz RI, Grant SFA. Genetic determinants of childhood obesity[J]. Mol Diagn Ther, 2020, 24(6): 653-663. [25] Dassie F, Favaretto F, Bettini S, et al. Alström syndrome: an ultra-rare monogenic disorder as a model for insulin resistance, type 2 diabetes mellitus and obesity[J]. Endocrine, 2021, 71(3): 618-625. [26] Kang S. Adipose tissue malfunction drives metabolic dysfunction in Alström Syndrome[J]. Diabetes, 2021, 70(2): 323-325. [27] Geberhiwot T, Baig S, Obringer C, et al. Relative adipose tissue failure in Alström Syndrome drives obesity-induced insulin resistance[J]. Diabetes, 2021, 70(2): 364-376. [28] Frölander HE, Möller C, Rudner M, et al. Theory-of-mind in individuals with Alström syndrome is related to executive functions, and verbal ability[J]. Front Psychol, 2015, 6: 1426. doi: 10.3389/fpsyg.2015.01426. eCollection 2015. [29] Bettini S, Bombonato G, Dassie F, et al. Liver fibrosis and steatosis in Alström Syndrome: a genetic model for metabolic syndrome[J]. Diagnostics(Basel), 2021, 11(5). doi: 10.3390/diagnostics11050797. [30] Marshall JD, Bronson RT, Collin GB, et al. New Alström syndrome phenotypes based on the evaluation of 182 cases[J]. Arch Intern Med, 2005, 165(6): 675-683. [31] Brofferio A, Sachdev V, Hannoush H, et al. Characteristics of cardiomyopathy in Alström syndrome: prospective single-center data on 38 patients[J]. Mol Genet Metab, 2017, 121(4): 336-343. [32] Aksoy F, Ozgur T, Dundar HZ, et al. Liver transplantation in Alstrom Syndrome: a case report[J]. Exp Clin Transplant, 2021. doi: 10.6002/ect.2020.0006. [33] Gheller F, Gallo S, Trevisi P, et al. Cochlear implants in Alström Syndrome[J]. Ann Otol Rhinol Laryngol, 2020, 129(8): 833-837. [34] Baig S, Veeranna V, Bolton S, et al. Treatment with PBI-4050 in patients with Alström syndrome: study protocol for a phase 2, single-Centre, single-arm, open-label trial[J]. BMC Endocr Disord, 2018, 18(1): 88. [35] Haqq AM, Chung WK, Dollfus H, et al. Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period[J]. Lancet Diabetes Endocrinol, 2022, 10(12): 859-868. |
| [1] | 张媛 李英敏 冯月秋 常彩云 潘华伟 王束玫. 血清脂联素水平与肥胖、胰岛素抵抗的关系探讨[J]. 山东大学学报(医学版), 2209, 47(6): 124-. |
| [2] | 刘雯,冯文娟,杨阳,纪昌丽,晁岚. 体质量指数对卵巢正常反应患者累积分娩率的影响[J]. 山东大学学报 (医学版), 2024, 62(3): 54-60. |
| [3] | 梁中昊,庄向华,黄珊,韩晓琳,华梦羽,琚丽萍,陈诗鸿. 饮食诱导肥胖雌鼠棕色脂肪组织蛋白质组学分析[J]. 山东大学学报 (医学版), 2024, 62(2): 10-19. |
| [4] | 范佳旭, 成芳,乔俊鹏,费海程,陈学禹,赵云,贾红英. 中介或混杂因素:是否应调整肥胖以估计三卤甲烷对甲状腺功能的影响[J]. 山东大学学报 (医学版), 2024, 62(1): 102-110. |
| [5] | 于丹凤,曹娟,于世佳,杜鲁涛,侯新国. 电化学发光法与液相色谱-串联质谱法评估糖尿病患者维生素D缺乏程度的效能比较与界值确定[J]. 山东大学学报 (医学版), 2023, 61(7): 90-95. |
| [6] | 李金泉,高美芳,闫飞,董明. 136例2型糖尿病患者肌肉痉挛的发生频率及危险因素[J]. 山东大学学报 (医学版), 2023, 61(5): 20-24. |
| [7] | 张天鑫,张婷,黄鑫,韩佳沂,王淑康. 氨基酸与2型糖尿病因果关系的孟德尔随机化分析[J]. 山东大学学报 (医学版), 2023, 61(5): 102-107. |
| [8] | 黄珊,娄能俊,韩晓琳,梁中昊,华梦羽,庄向华,陈诗鸿. 高糖环境下Lipin1对神经元代谢组学的影响[J]. 山东大学学报 (医学版), 2023, 61(2): 1-8. |
| [9] | 包瑾瑾,刘庆燕,孙甜甜,陈青,刘佳. 糖尿病相关抗体阳性合并MODY14相关APPL1基因突变1例[J]. 山东大学学报 (医学版), 2023, 61(12): 113-118. |
| [10] | 韩梅,孟维静,陶子琨,杨希,徐雅琪,穆华夏,卜伟晓,王素珍,石福艳. 基于G-计算的高血压、抑郁在2型糖尿病与认知功能之间的因果多中介分析[J]. 山东大学学报 (医学版), 2023, 61(10): 101-108. |
| [11] | 宋宜耘,于慧,高兆丽,李宪花. 基于SIRT1/PGC-1α通路探讨葡萄籽原花青素提取物对糖尿病肾脏疾病大鼠的保护作用[J]. 山东大学学报 (医学版), 2023, 61(1): 1-9. |
| [12] | 李涛,杨春林,杜通,李亨,王聪聪,李晓丽,段瑞生,张蓬. 糖尿病对重症肌无力NK细胞亚型及功能的影响[J]. 山东大学学报 (医学版), 2022, 60(5): 31-36. |
| [13] | 唐钦连,张玉超,赵蕙琛,马小莉,于民民,刘元涛. 携带成对盒4基因突变早发糖尿病1例报道并文献复习[J]. 山东大学学报 (医学版), 2022, 60(5): 104-108. |
| [14] | 赵美茹,朱迪,刘淋,管庆波,张栩. 简易胰岛素抵抗指标与698例2型糖尿病患者发生高尿酸血症风险的关联[J]. 山东大学学报 (医学版), 2022, 60(12): 44-51. |
| [15] | 于书卷,王美娟,陈丽,曹英娟,吕晓燕,刘雪燕,林鹏,颜景政. 老年2型糖尿病患者轻度认知功能障碍的影响因素[J]. 山东大学学报 (医学版), 2022, 60(11): 108-112. |
|
